Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02142777 · ClinicalTrials.gov registry record · Phase 1
S-Equol in Alzheimer's Disease (SEAD) Trial
A Phase 1 study, sponsored by Russell Swerdlow, MD.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT02142777: Completed Phase 1 study, sponsored by Russell Swerdlow, MD.
NCT02142777 is a Phase 1 study that has completed, run by Russell Swerdlow, MD. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02142777, a Phase 1 study, has completed, sponsored by Russell Swerdlow, MD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if S-equol could benefit persons with Alzheimer's Disease (AD).
Interventions
- DRUG Placebo
- DRUG S -Equol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02142777
The ClinicalTrials.gov registry entry for NCT02142777 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Russell Swerdlow, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02142777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02142777 about?
NCT02142777 is a clinical study titled "S-Equol in Alzheimer's Disease (SEAD) Trial". The purpose of this study is to determine if S-equol could benefit persons with Alzheimer's Disease (AD).
What is the current status of trial NCT02142777?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2014-07. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02142777?
The interventions under investigation include: Placebo (DRUG), S -Equol (DRUG).
Who is sponsoring clinical trial NCT02142777?
This trial is sponsored by Russell Swerdlow, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.